[1]
H. Arshad and G. A. Sheikh, “Frequency of UTI in patients taking Empagliflozin versus Dapagliflozin in patients with type 2 diabetes Mellitus”, IJBR, vol. 3, no. 5, pp. 230–234, May 2025, doi: 10.70749/ijbr.v3i5.1206.